(Source: Kontrol Technologies.)
  • Kontrol Technologies (KNR) who manufactures smart buildings and cities has been selected by a municipal customer for net zero emissions building design
  • It has also been awarded its second USA patent for System and Method for Detecting Airborne Pathogens
  • The patent that has been awarded works by having an air inflow channel portion at a top end and the air inflow channel being oriented substantially vertically
  • Kontrol Technologies is a Canadian public company and is a leader in smart buildings and cities through IoT and more
  • Kontrol Technologies (KNR) is down 6.85 per cent, trading at C$0.34 at 12:41 pm EST

Kontrol Technologies (NEO:KNR) who manufactures smart buildings and cities has been selected by a municipal customer for net zero emissions building design.

In other good news for the company, it has also been awarded its second USA patent for System and Method for Detecting Airborne Pathogens.

“We are pleased to continue to grow our net zero emission business with a new municipal opportunity,” said Paul Ghezzi, CEO of Kontrol Technologies.

“In addition to growing our operating business we continue to add to our expanding intellectual property with our second USA patent for airborne pathogen monitoring,” added Ghezzi.

The patent that has been awarded works by having an air inflow channel portion at a top end and the air inflow channel being oriented substantially vertically.

The device also has a sensing unit for determining a volume of liquid in the collection chamber, wherein the cooling unit is controlled in response to signals generated by the sensing unit.

According to the company, by 2050 every building in the world will need to achieve the target goal of net-zero energy to help reduce the impact of climate change.

Kontrol Technologies is a Canadian public company and is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. 

Kontrol Technologies (KNR) is down 6.85 per cent, trading at C$0.34 at 12:41 pm EST.

More From The Market Online

Pathologists group accepts Telo Genomics’ test for rare blood cancer

The College of American Pathologists accepts the Telo Genomics' (TSXV:TELO) submission of a test for a rare blood cancer.

From robotic limbs to new highs, NVIDIA stock is on a roll

NVIDIA Corp. (NDAQ:NVDA; NEO:NVDA) opens Tuesday trading on a positive note, showing a significant upward trend.

Hillcrest and Ocean Batteries deploy new energy storage systems

Hillcrest Energy Technologies (CSE:HEAT) completes its joint development agreement with Ocean Batteries to deliver its unique equipment.

ARway integrates tech with Apple’s new AI for Vision Pro

Arway.ai (CSE:ARWY) integrates Apple’s (NDAQ:AAPL) new enterprise APIs with its augmented reality solutions.